IVF
NasdaqINVO FERTILITY, INC.
Technology · Surgical & Medical Instruments & Apparatus
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$4.2M
2021
$822,196
2022
$3.0M
2023
$6.5M
2024
$6.8M
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$6.8M
Net Income$23.3M
Gross Profit—
Oper Income$-7.2M
EPS (dil)$-214.64
Rev/sh$3.83
FCF/sh$-3.95
Book/sh$4.04
Gross M—
Oper M-105.8%
Profit M340.9%
FCF M-103.2%
ROE322.8%
ROA115.3%
ROIC-96.8%
R&D/Rev0.1%
Rev Y/Y4.7%
Rev 3Y CAGR102.6%
EPS Y/Y94.3%
EPS 3Y CAGR—
FCF 3Y CAGR—
Payout—
Div/sh—
Shs Chg Y/Y+4557.2%
Current Ratio0.27
Quick Ratio0.25
Debt/Eq0.30
Int Coverage-5.6×
Net Debt$204,993
Total Debt$2.2M
Cash & Eq$2.0M
Total Assets$20.2M
Oper CF$-7.0M
Capex$43,412
Free CF$-7.1M
Buybacks—
Equity$7.2M
Liabilities$13.0M
Shs Outstand0.00B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4.2M | $822,196 | $3.0M | $6.5M | $6.8M |
| Gross Profit | $4.0M | $490,673 | — | — | — |
| Operating Income | $-5.2M | $-10.6M | $-6.8M | $-6.6M | $-7.2M |
| Net Income | $-6.7M | $-10.9M | $152,138 | $-9.3M | $23.3M |
| Diluted EPS | $-0.63 | $-17.97 | $-67.37 | $-3782.65 | $-214.64 |
| Operating Cash Flow | $-6.0M | $-6.6M | $-4.8M | $-3.0M | $-7.0M |
| Free Cash Flow | $-6.4M | $-6.6M | $-5.2M | $-3.2M | $-7.1M |
COMMUNITY · $IVF0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.